3,4 The label expansions were granted on the basis of clinical and/or in vitro data demonstrating responsiveness across 564 variants for Alyftrek and 521 variants for Trikafta
Other therapies for low libido during the menopause transition include systemic hormone replacement therapy (HRT)
Thats what Ozempic the first semaglutide drug was developed to treat
Obesity and gonadal function of women
Were interested in exploring how continuous data from a wearable device can provide invaluable insights into a patients activity levels, heart rate, and body composition, giving clinicians a more holistic view of treatment impact and allowing for more timely, data-driven adjustments to their care plan, Putman said
The mechanism is well-established, thoroughly documented, and essentially unavoidable given how these drugs work